Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol.
BACKGROUND
There has been a global increase in the use of herbal medicinal products (HMPs). About a quarter of UK adults use HMPs, bought over the counter by self-prescription and often not disclosed to healthcare professionals. Potential herb-drug interaction is a clinical concern, with older people at greater risk because of co-morbidities and slower clearance of pharmacologically active compounds. While there is a good understanding of general herbal medicine use by older people, less is known about the extent and implications of concurrent use with prescription medicines. The aim of this systematic review is to assess the prevalence, patterns, safety issues and other factors associated with concurrent prescription and herbal medicines use among older adults.


METHODS
Systematic electronic searches of MEDLINE, PsychINFO, Excerpta Medica dataBASE (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), Web of Science and Cochrane from inception till present for studies reporting the concurrent use of prescription medicines with HMPs in older adults (≥65 years). Lateral searching via related citation (PubMed) and checking reference lists of identified studies will be performed. Two reviewers will independently screen studies, extract data and appraise methodological quality using the Joanna Briggs Institute checklist for prevalence data and the Critical Appraisal Skills Programme (CASP) checklist. Qualitative and quantitative studies from all settings will be included. Non-empirical papers, in vitro experiments and animal studies will be excluded. Primary outcomes are prevalence and patterns of concurrent use, number and types of prescription and HMPs and adverse reactions reported. Secondary outcomes are disclosure of HMP use to healthcare professionals and cost of HMPs. A narrative synthesis of included studies will be performed to summarise the evidence.


CONCLUSIONS
This review will synthesise and critically appraise current knowledge on the concurrent use of drugs and HMPs by older adults and thus provide a better understanding of the issue. It will also identify any gaps in knowledge. By establishing safety issues associated with concurrent use, it will also inform strategies that can help practitioners to identify and manage older people at potential risk of herb-drug interactions.


BACKGROUND
PROSPERO CRD42014009091.
Centre for Research in Primary and Community Care (CRIPACC), University of Hertfordshire, Hatfield, UK.|Patient Safety Domain, Nursing Directorate, NHS England, London, UK.
Taofikat
T
Agbabiaka
Institute of Health Research, University of Exeter Medical School, Exeter, UK. b.wider@exeter.ac.uk.
Barbara
B
Wider
Institute of Health Research, University of Exeter Medical School, Exeter, UK.
Leala Kay
LK
Watson
Centre for Research in Primary and Community Care (CRIPACC), University of Hertfordshire, Hatfield, UK.
Claire
C
Goodman
D000368:Aged; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008517:Phytotherapy; D055553:Prescription Drugs / Q000627:therapeutic use*; D012107:Research Design; D000078202:Systematic Reviews as Topic
D004365:Drugs, Chinese Herbal; D055553:Prescription Drugs
Adverse reaction; Concurrent use; Elderly; Herb-drug interaction; Herbal medicinal product; Prescription drug; Prevalence; Safety